Mankind Pharma Ltd.
2,521.40+34.5 (+1.39%)
3 Jul, 1:59 PM
Stock News
Mankind Pharma Ltd. latest news covering earnings updates, regulatory announcements, analyst actions and market-moving events.
LiveMint
Govt plans audit of 81 years of drug approvals amid safety concerns
Sheetal Arora, CEO of Mankind Pharma, stated that the initiative to reconcile drug approval records will enhance regulatory oversight and improve the reliability of India's pharmaceutical approval records, representing a significant step towards better data governance.
3rd Jul '26 3:30 am
Read full article on livemint.com
Economic Times
Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery
Mankind Pharma has partnered with Denovo Sciences to enhance drug discovery through artificial intelligence, aiming to reduce development timelines and improve the quality of drug candidates by integrating AI with human expertise.
1st Jul '26 8:07 am
Read full article on economictimes.indiatimes.com
LiveMint
Mazagon Dock to Torrent Pharma - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment
Jay Thakkar of ICICI Securities recommends buying Mankind Pharma Futures in the range of 2,540-2,560 with a stop loss below 2,480 and targets of 2,620-2,660, indicating a breakout from a falling trend line and increased open interest suggesting further upward movement.
1st Jul '26 4:18 am
Read full article on livemint.com